Share this post on:

Product Name :
Farletuzumab ecteribulin

Search keywords :

drugId :

Target Vo:
Folate receptor alpha

Target Vo Short Name :

Tubulin polymerisation inhibitors

First Approval Country :

First Approval Date Filter:

Origin Company_Name :
Eisai Co Ltd

Active Company_Name :
Bristol-Myers Squibb Company

Active Indication_Name:
Ovarian Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites:
Popular product recommendations:
FGFR2/CD332 Antibody
STING Antibody
Phospho-AMPK alpha 1 (Ser496) Antibody: Phospho-AMPK alpha 1 (Ser496) Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 64 kDa, targeting to Phospho-AMPK alpha 1 (Ser496). It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related